Retatrutide appears to be a new treatment in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, demonstrates promising results in investigations. By boosting these receptors, Retatrutide reduces hunger pangs, {promotesinsulin secretion, and ultimately contributes to significant reduction in body mass. W… Read More